Drug intelligence / Profile preview

Triobit

Development stage: Unknown
Lead developer: VTS Life Sciences
Modality: Small Molecules
Administration: Oral

Overview

Triobit is an oral dietary supplement marketed by VTS Life Sciences, formulated as a combination of carrot extract powder, astaxanthin, and lycopene. Astaxanthin is a keto-carotenoid belonging to the xanthophyll class, recognized for its potent antioxidant properties. The product is designed to provide systemic antioxidant support, with marketing claims suggesting benefits for vision, skin health, immunity, and the maintenance of heart, brain, and prostate health. As a nutraceutical rather than a prescription pharmaceutical, it is used for general health maintenance and metabolism boosting.

Brand names: Triobit

Beyond the preview

Go deeper on Triobit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triobit.

Explore the full profile